EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Lipidomics signature in post-COVID patient sera and its influence on the prolonged inflammatory response

P F Garrido, L S Castillo-Peinado, F Priego-Capote, I Barrio, Á Piñeiro, M J Domínguez-Santalla, E Rodríguez-Ruiz, R Garcia-Fandino

Journal of Infection and Public Health · 2024

DOI: 10.1016/j.jiph.2024.01.017 ↗

At a glance

Journal article in Journal of Infection and Public Health, 2024. Written by P F Garrido and 7 co-authors. Institution: Institute of Biocomputation and Physics of Complex Systems (BIFI), Joint Units IQFR-CSIC-BIFI, and GBsC-CSIC-BIFI, Universidad de Zaragoza, Zaragoza …. Major MEDLINE topics: Lipidomics, COVID-19. Cited 19 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY 4.0). Funded by: Centro Singular de Investigación de Galicia, Agencia Estatal de Investigacion, European Regional Development Fund.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BACKGROUND: The ongoing issues with post-COVID conditions (PCC), where symptoms persist long after the initial infection, highlight the need for research into blood lipid changes in these patients. While most studies focus on the acute phase of COVID-19, there's a significant lack of information on the lipidomic changes that occur in the later stages of the disease. Addressing this knowledge gap is critical for understanding the long-term effects of COVID-19 and could be key to developing personalized treatments for those suffering from PCC. METHODS: We employed untargeted lipidomics to analyze plasma samples from 147 PCC patients, assessing nearly 400 polar lipids. Data mining (DM) and machine learning (ML) tools were utilized to decode the results and ascertain significant lipidomic patterns. RESULTS: The study uncovered substantial changes in various lipid subclasses, presenting a detailed profile of the polar lipid fraction in PCC patients. These alterations correlated with ongoing inflammation and immune response. Notably, there were elevated levels of lysophosphatidylglycerols (LPGs) and phosphatidylethanolamines (PEs), and reduced levels of lysophosphatidylcholines (LPCs), suggesting these as potential lipid biomarkers for PCC. The lipidomic signatures indicated specific anionic lipid changes, implicating antimicrobial peptides (AMPs) in inflammation. Associations between particular medications and symptoms were also suggested. Classification models, such as multinomial regression (MR) and random forest (RF), successfully differentiated between symptomatic and asymptomatic PCC groups using lipidomic profiles. CONCLUSIONS: The study's groundbreaking discovery of specific lipidomic disruptions in PCC patients marks a significant stride in the quest to comprehend and combat this condition. The identified lipid biomarkers not only pave the way for novel diagnostic tools but also hold the promise to tailor individualized therapeutic strategies, potentially revolutionizing the clinical approach to managing PCC and improving patient care.

Subjects

MeSH terms (MEDLINE)

LipidomicsCOVID-19HumansBiomarkersInflammationLipids

Author keywords

Lipidomic signaturePost-COVID patientsPredictive modeling for inflammatory responseProlonged inflammatory response

Substances

BiomarkersLipids

Authors and institutions

  • Institute of Biocomputation and Physics of Complex Systems (BIFI), Joint Units IQFR-CSIC-BIFI, and GBsC-CSIC-BIFI, Universidad de Zaragoza, Zaragoza 50018, Spain.
  • Department of Analytical Chemistry, University of Córdoba, Annex C-3 Building, Campus of Rabanales, Córdoba 14071, Spain; Maimónides Institute for Biomedical Research (IMIBIC), Reina Sofía University Hospital, Universit…
  • Department of Mathematics, University of the Basque Country UPV/EHU, Leioa 48940, Spain; Basque Center for Applied Mathematics, BCAM, Bilbao 48009, Spain.
  • Soft Matter & Molecular Biophysics Group, Department of Applied Physics, Faculty of Physics, University of Santiago de Compostela, Spain.
  • Internal Medicine Department, University Clinic Hospital of Santiago de Compostela (CHUS), Galician Public Health System (SERGAS), Santiago de Compostela, Spain.
  • Intensive Care Medicine Department, University Clinic Hospital of Santiago de Compostela (CHUS), Galician Public Health System (SERGAS), Santiago de Compostela, Spain; Simulation, Life Support & Intensive Care Research…

Funding

  • Centro Singular de Investigación de Galicia
  • Agencia Estatal de Investigacion
  • European Regional Development Fund
  • Xunta de Galicia
  • Basque Government
  • BCAM
  • Ministerio de Ciencia e Innovación

Cite

APA

Garrido, P. F., Castillo-Peinado, L. S., Priego-Capote, F., Barrio, I., Piñeiro, Á., Domínguez-Santalla, M. J., Rodríguez-Ruiz, E., & Garcia-Fandino, R. (2024). Lipidomics signature in post-COVID patient sera and its influence on the prolonged inflammatory response. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.01.017

Vancouver

Garrido PF, Castillo-Peinado LS, Priego-Capote F, Barrio I, Piñeiro Á, Domínguez-Santalla MJ, et al. Lipidomics signature in post-COVID patient sera and its influence on the prolonged inflammatory response. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.01.017

BibTeX
@article{Garrido2024,
  author = {Garrido, P F and Castillo-Peinado, L S and Priego-Capote, F and Barrio, I and Piñeiro, Á and Domínguez-Santalla, M J and Rodríguez-Ruiz, E and Garcia-Fandino, R},
  title = {Lipidomics signature in post-COVID patient sera and its influence on the prolonged inflammatory response},
  journal = {Journal of Infection and Public Health},
  year = {2024},
  doi = {10.1016/j.jiph.2024.01.017}
}
Start for free →